Navigation Links
New vaccine delivery may be more effective against measles
Date:9/28/2009

e, as this would facilitate mass vaccination in developing world countries where transport, storage, administration costs and other complexities have limited vaccine coverage by 70 percent."

Dr. Ohtake's study used a combination of mild spray drying process conditions and unique stabilizers to produce stable dry powders with excellent preservation of vaccine activity. The potency of the dried vaccine was then tested while being stored at different temperatures over several week-long periods. The results found that the dry-powdered aerosol was stable for at least eight weeks at 37C, surpassing the World Health Organization requirement for heat stability of one week at similar storage conditions.

"This study offers hope for developing countries that desperately need more stable and efficient vaccination methods," says Dr. Ohtake. "This new method could potentially offer safer, more affordable and effective treatments to patients that need them the most."


'/>"/>

Contact: Rosalind D'Eugenio
rd@ecius.net
203-325-8772
American Association of Pharmaceutical Scientists
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
3. Vaccine Stops Alzheimers Brain Tangles
4. Human Papilloma Virus vaccines may decrease chances of oral cancer
5. U.S. Teens Fall Short on Vaccine Coverage
6. Nasal Anthrax Vaccine Proves Effective in Animal Study
7. Hot ice, measuring depression, perfect invisibility and flu vaccine incentives
8. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
9. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
10. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
11. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e-USNewswire/--WhenmostpeopleheartheacronymTMJ,the...tientsthehelptheyneed.TMJstandsfortheTemporal-Mand...connectswithyourskull(temporalbone). ,, Themost...ithchewing,clickingorpoppingofthejaw.Butmanyothers...aches,fatigue,sleepdisturbances,irritability,aloss...
(Date:11/25/2009)...wswire/--Thanksgivingmealswillbedeliveredtoapproxi...eathankstoFaithInAction/VolunteerActionforAging,ap...fSCANHealthPlan.Formorethan17yearstheseorganizatio...nksgivingmealstoseniorsinneedinLongBeach,Lakewood,...ities. ,, "Ourwarmholidaymealsaredeliveredtopeo...
(Date:11/25/2009)...cancer who were treated with cisplatin-based chemo...urological side effects and Raynaud-like phenomena... according to a new study published online Novembe...ute . , Marianne Brydy, M.D., of the Department ...gen, Norway, and colleagues conducted a cross-sect...
(Date:11/25/2009)...umatoid arthritis, could help newly diagnosed diab...5 (HealthDay News) -- A drug commonly used to trea...now also shows some promise in helping patients ne... rituximab (Rituxan), helped patients keep produci...ase had destroyed some of their pancreatic beta ce...
(Date:11/25/2009)... MISSIONSkincare ®isproudtosupportGNC,seffort...nnualSt.Jude ThanksandGiving campaign,$1fromthepur...TM)LipBalm willbedonatedtoSt.Jude.Additionally,GNC...onatcheckoutatoneoftheir5,000+retaillocationsoratG...uringtheir2009 ThanksandGiving campaign. ,, "We...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2
...idney disease , , EL SEGUNDO, Calif., April 23 D...ices for those diagnosed with chronic kidney disea...er online resource for kidney disease - received a...urce Center, a national clearinghouse for consumer...
...s (tube current flow) according to a patient,s bod...ic patients during CT, according to a study perfor... Cleveland, OH. , Phantoms that were 10, 16 and...de using various kVp and mAs levels. The lowest do...
...tions, LLC, a subsidiary of Wound Management Techn...ed today that it will exhibit at the 22nd Annual S...Society (SAWC/WHS) conference in Dallas April 26-2...ng of wound care clinicians in the United States. ...
...and Feeling Better , , WASHINGTON, April 23 The ...pter (LFAGW) will offer the 14th Annual Symposium ...om 9:30 a.m.-12:45 p.m. at the Carnegie Endowment ...ton area patients with lupus --- 90 percent of who...
...anipulation poses, study finds , , THURSDA...nverted adult cells into embryonic-like stem cells...manipulation. , Gene manipulation is an older meth...altering them could lead to the development of man...
...logists a fun, alternative method to using a stand... images, according to a study performed at the New...Center in New York, NY. The remote may also offer ... radiologists to navigate through patient images u...
Other Medicine News:Health News:DaVita Wins Silver in Web Health Awards 2Health News:Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas 2Health News:Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas 3Health News:LFAGW to Offer Free Lupus Symposium on May 16 for Patients and Families 2Health News:Scientists Find New Way to Create Stem Cells 2Health News:Popular gaming system may offer radiologists an alternative way to view patient images 2
(Date:11/25/2009)....25/PRNewswire-FirstCall/--HeartWareInternational,...ovideroflessinvasive,miniaturizedcirculatorysuppor...heartfailure,todayannouncedthatitisscheduledtomake...ealthCareConferenceat8:00amESTonWednesday,December...otel,December1-2. ,, AlivewebcastoftheCompany,s...
(Date:11/24/2009)...e-Asia/--ChindexInternational,Inc.,("Chindex")(Nas...estern,healthcareproductsandservicesinthePeople,sR...tendthe21stAnnualPiperJaffray,"Unplugged"HealthCar...PalaceHotel. , Managementiscurrentlyscheduled...oldone-on-onemeetingsthroughouttheday.Awebcast,oft...
(Date:11/24/2009)...re-FirstCall/--Endologix,Inc.(Nasdaq: ELGX ),devel...s,announcedtodaythatithasfiledamotiontostay,ordisc...itbroughtagainstitinOctober2009byCook,Inc.Themotio...lis,Indiana. ,, Endologixhasrequestedthatthesta...arkOffice(USPTO)conductsproceedingstore-examinethe...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2William Dwyer Named to PerfectServe Advisory Board 57496 1William Dwyer Named to PerfectServe Advisory Board 57496 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 1Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 3Cyberonics to Present at Maxim Group Growth Conference 57492 1Cyberonics to Present at Maxim Group Growth Conference 57492 2
...a,Pharmaceuticals, Inc., a privately-held biotechn...ment of novel therapeutics for cardiovascular and,... raised $60 million in a,preferred stock financing...la,s two lead antithrombotic clinical candidates, ...eloping as best-in-class compounds to,replace exis...
...ceuticals,Inc., announced today it has initiated a...asiliximab) for the treatment of noninfectious uve...inflammation of the eye. The,randomized, double-ma...afety and efficacy of Simulect as maintenance ther...l undergo tapering of concomitant,immunosuppressiv...
Other Medicine Technology:Portola Completes $60 Million Financing to Advance Its Therapeutic Programs 2Portola Completes $60 Million Financing to Advance Its Therapeutic Programs 3Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis 2
TME 66 S
TME 64 S
TME 60 S
...r individual indications. XCaliber covers a compre...novative composite plastic material, XCaliber is s...ter. This means it's easier to handle, easier to a...pre-assembled, packaged sterile, and ready to use ...
Medicine Products: